Vigneshh Pharma Impex Profile
Key Indicators
- Authorised Capital ₹ 7.50 M
as on 17-07-2024
- Paid Up Capital ₹ 7.00 M
as on 17-07-2024
- Company Age 40 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 1.55 Cr
as on 17-07-2024
- Satisfied Charges ₹ 3.00 M
as on 17-07-2024
- Revenue 117.85%
(FY 2023)
- Profit 633.08%
(FY 2023)
- Ebitda 620.44%
(FY 2023)
- Net Worth 24.11%
(FY 2023)
- Total Assets 45.69%
(FY 2023)
About Vigneshh Pharma Impex
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 M and a paid-up capital of Rs 7.00 M.
The company currently has active open charges totaling ₹1.55 Cr. The company has closed loans amounting to ₹3.00 M, as per Ministry of Corporate Affairs (MCA) records.
Siddhartha Ghatak, Aparna Maitra, and Pradyot Maitra serve as directors at the Company.
- CIN/LLPIN
U51900MH1984PTC034426
- Company No.
034426
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
30 Oct 1984
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Vigneshh Pharma Impex Private Limited offer?
Vigneshh Pharma Impex Private Limited offers a wide range of products and services, including Pharma Ingredients & Raw Materials, Anti Infective API, Chemical Reagents & Catalysts, Ammonium Compound.
Who are the key members and board of directors at Vigneshh Pharma Impex?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Siddhartha Ghatak  | Director | 01-Apr-2020 | Current |
| Aparna Maitra | Director | 06-Jul-2010 | Current |
| Pradyot Maitra | Director | 15-Apr-2005 | Current |
Financial Performance and Corporate Structure Insights of Vigneshh Pharma Impex.
Vigneshh Pharma Impex Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 117.85% increase. The company also saw a substantial improvement in profitability, with a 633.08% increase in profit. The company's net worth Soared by an impressive increase of 24.11%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Vigneshh Pharma Impex?
In 2023, Vigneshh Pharma Impex had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Chandralok Exim Private LimitedActive 31 years 9 monthsSiddhartha Ghatak, Aparna Maitra and 1 more are mutual person
- Chetak Resources Private LimitedActive 24 years 2 months
Siddhartha Ghatak, Aparna Maitra and 1 more are mutual person
- One Window Financial Services Private LimitedActive 5 years 3 months
Siddhartha Ghatak is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Hdfc Bank Limited Creation Date: 09 Dec 2021 | ₹1.10 M | Open |
Hdfc Bank Limited Creation Date: 09 Mar 2020 | ₹1.00 Cr | Open |
Bank Of India Creation Date: 13 Mar 2015 | ₹0.79 M | Open |
How Many Employees Work at Vigneshh Pharma Impex?
Unlock and access historical data on people associated with Vigneshh Pharma Impex, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Vigneshh Pharma Impex, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Vigneshh Pharma Impex's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
